Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial-Reference-Cited by-同舟云学术

Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial

Published:2011-01 Issue:1 Volume:64 Page:64-70
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Langley Richard G.,Paller Amy S.,Hebert Adelaide A.,Creamer Kara,Weng Haoling H.,Jahreis Angelika,Globe Denise,Patel Vaishali,Orlow Seth J.

Publisher

Elsevier BV

Subject

Dermatology

Reference23 articles.

1. Therapy options for psoriasis in childhood and adolescence;Zappel;J Dtsch Dermatol Ges,2004

2. Childhood psoriasis;Rogers;Curr Opin Pediatr,2002

3. Recognition and treatment of psoriasis in children;Leman;Curr Paediatr,2003

4. A comparative study of pediatric onset psoriasis with adult onset psoriasis;Raychaudhuri;Pediatr Dermatol,2000

5. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey;Krueger;Arch Dermatol,2001

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis;Dermatologic Clinics;2024-07

2. The Impact on Families of Children With Congenital Upper Extremity Differences;The Journal of Hand Surgery;2024-07

3. Biological therapies for the treatment of psoriasis in pediatrics;Expert Opinion on Biological Therapy;2023-11-10

4. Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics;Pediatric Health, Medicine and Therapeutics;2023-11

5. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients;Expert Opinion on Drug Safety;2023-01-02